cardiac allograft vasculopathy
Showing 1 - 25 of 35
Cardiac Allograft Vasculopathy Trial in Canada (ICA, PET)
Not yet recruiting
- Cardiac Allograft Vasculopathy
- ICA
- PET
-
Calgary, Alberta, Canada
- +4 more
Oct 12, 2023
Microvascular Cardiac Allograft Vasculopathy Trial
Recruiting
- Cardiac Allograft Vasculopathy
- Echocardiography
- +7 more
-
Berlin, GermanyDHZC Deutsches Herzzentrum der Charité
Apr 12, 2023
Microvascular Disease as Assessed by PET and Graft Injury by
Not yet recruiting
- Cardiac Allograft Vasculopathy
- +2 more
- Blood draw to measure the levels of dd-cf DNA
-
New Haven, ConnecticutYale New Haven Health
Mar 6, 2023
Cardiac Allograft Vasculopathy Trial in Seoul
Recruiting
- Cardiac Allograft Vasculopathy
-
Seoul, Korea, Republic ofSamsung Medical Center
Sep 6, 2022
Cardiac Allograft Vasculopathy Trial in Los Angeles (Macitentan)
Recruiting
- Cardiac Allograft Vasculopathy
-
Los Angeles, CaliforniaRonald Regan UCLA Medical Center
May 9, 2022
Early Post Transplant Cardiac Allograft Vasculopathy
Active, not recruiting
- Cardiac Allograft Vasculopathy
-
Ottawa, Ontario, CanadaUniversity of Ottawa Heart Institute
Feb 10, 2022
Cardiac Allograft Vasculopathy, Heart Transplant Trial in Vancouver, Ottawa, Toronto (Placebo, aspirin, Clopidogrel)
Recruiting
- Cardiac Allograft Vasculopathy
- Heart Transplant
- Placebo
- +2 more
-
Vancouver, British Columbia, Canada
- +2 more
Feb 10, 2022
Cardiac Allograft Vasculopathy Trial in Italy, Netherlands (Everolimus-Eluting Bioresorbable Vascular Scaffold (ABSORB))
Completed
- Cardiac Allograft Vasculopathy
- Everolimus-Eluting Bioresorbable Vascular Scaffold (ABSORB)
-
Cagliari, Italy
- +9 more
Sep 29, 2021
Donor-derived Cell-Free DNA asBiomarker in Cardiac Allograft
Completed
- Cardiac Allograft Vasculopathy
- Donor-derived Cell Free DNA
-
Majadahonda, Madrid, SpainUniversity Hospital Puerta de Hierro
Sep 15, 2021
Pediatric Heart Transplantation, Immunosuppression, Chronic Kidney Diseases Trial in United States (Everolimus, Tacrolimus,
Active, not recruiting
- Pediatric Heart Transplantation
- +6 more
- Everolimus
- +2 more
-
Birmingham, Alabama
- +24 more
Sep 2, 2021
Antibody-mediated Rejection, Hyperacute Rejection of Cardiac Transplant, Left Ventricular Dysfunction Trial in Los Angeles
Completed
- Antibody-mediated Rejection
- +4 more
-
Los Angeles, CaliforniaCedars Sinai Medical Center, Heart Institute
Apr 30, 2021
A P2X7R Single Nucleotide Mutation Promotes Chronic Allograft
Completed
- Cardiac Allograft Vasculopathy
-
Boston, MassachusettsBoston Children's Hospital
Mar 2, 2021
Cardiac Allograft Vasculopathy Trial in Denmark, Finland, Sweden (Evolocumab, Placebo)
Recruiting
- Cardiac Allograft Vasculopathy
- Evolocumab
- Placebo
-
Copenhagen, Denmark
- +4 more
Feb 25, 2021
Cardiac Allograft Vasculopathy, Heart Transplant Recipients Trial in United States (Rituximab induction/conventional
Terminated
- Cardiac Allograft Vasculopathy
- Heart Transplant Recipients
- Rituximab induction/conventional immunosuppression (tacrolimus, MMF, and steroid taper)
- Rituximab placebo/conventional immunosuppression (tacrolimus, MMF, and steroid taper)
-
Beverly Hills, California
- +23 more
Aug 12, 2020
Cardiac Mitochondrial Function After Heart Transplantation
Enrolling by invitation
- Cardiac Allograft Vasculopathy
- +3 more
-
Aarhus, DenmarkAarhus University Hospital Department of Cardiology
Aug 10, 2020
Cardiac Allograft Vasculopathy, Heart Transplant Rejection Trial in Zagreb (Extracoropreal photopheresis)
Recruiting
- Cardiac Allograft Vasculopathy
- Heart Transplant Rejection
- Extracoropreal photopheresis
-
Zagreb, CroatiaUHC Zagreb
Jan 8, 2020
Cardiac Allograft Vasculopathy Trial in Minneapolis (Sildenafil, Placebo)
Withdrawn
- Cardiac Allograft Vasculopathy
- Sildenafil
- Placebo
-
Minneapolis, MinnesotaUniversity of Minnesota Medical Center
Oct 30, 2019
piTie-Salpetriere University Hospital
Completed
- Cardiac Transplant Disorder
- +7 more
- (no location specified)
Sep 24, 2019
Cardiac Allograft Vasculopathy Trial in Rochester (Perflutren Lipid Microsphere, RTMPE)
Completed
- Cardiac Allograft Vasculopathy
- Perflutren Lipid Microsphere
- RTMPE
-
Rochester, MinnesotaMayo Clinic in Rochester
May 27, 2019
Cardiac Allograft Vasculopathy Trial in Beverly Hills (Thymoglobulin)
Withdrawn
- Cardiac Allograft Vasculopathy
-
Beverly Hills, CaliforniaCedars-Sinai Medical Center
Mar 12, 2019
Cardiac Allograft Vasculopathy, Transplanted Heart Complication Trial in Copenhagen (Ivabradine, Placebo)
Unknown status
- Cardiac Allograft Vasculopathy
- Transplanted Heart Complication
- Ivabradine
- Placebo
-
Copenhagen, DenmarkDepartment of Cardiology, Copenhagen University Hospital, Rigsho
Mar 4, 2019
Cardiac Allograft Vasculopathy, Chronic Rejection of Cardiac Transplant, Graft Dysfunction Trial in Gothenburg (Diagnostic
Unknown status
- Cardiac Allograft Vasculopathy
- +2 more
- Diagnostic investigations
-
Gothenburg, SwedenSahlgrenska University Hospital
Jan 15, 2019
Cardiac Allograft Vasculopathy, Antibody Mediated Rejection Trial in Pittsburgh (device, drug, procedure)
Terminated
- Cardiac Allograft Vasculopathy
- Antibody Mediated Rejection
- Optical Coherence Tomography
- +2 more
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Medical Center
Sep 1, 2017